Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1

FASEB Journal

Volumn 24, Issue 11, 2010, Pages 4443-4458

  Gimm, Tina ^a   Wiese, Melanie ^a   Teschemacher, Barbara ^a   Deggerich, Anke ^b   Schödel, Johannes ^c   Knaup, Karl X ^a   Hackenbeck, Thomas ^a   Hellerbrand, Claus ^d   Amann, Kerstin ^a   Wiesener, Michael S ^a   Höning, Stefan ^b   Eckardt, Kai Uwe ^a   Warnecke, Christina ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Gene expression; Lipid metabolism; Promoter; Renal clear cell carcinoma

Indexed keywords

ADIPOPHILIN; FAT DROPLET; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE PROTEIN 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ASSESSMENT; CYTOKINE PRODUCTION; FATTY ACID OXIDATION; FATTY LIVER; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; KIDNEY CARCINOMA; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANOXIA; CARCINOMA, RENAL CELL; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY NEOPLASMS; LIPID METABOLISM; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; WNT1 PROTEIN;

EID: 78649805641     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-159806     Document Type: Article

References (52)

1. 2-regulated gene expression. FASEB J. 16, 1151-1162
2. Kaelin, W. G., Jr., and Ratcliffe, P. J. (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell. 30, 393-402
3. Maxwell, P. (2003) HIF-1: an oxygen response system with special relevance to the kidney. J. Am. Soc. Nephrol. 14, 2712-2722
4. Warnecke, C., Zaborowska, Z., Kurreck, J., Erdmann, V. A., Frei, U., Wiesener, M., and Eckardt, K. U. (2004) Differentiating the functional role of hypoxia-inducible factor (HIF)-1α and HIF-2α (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2α target gene in Hep3B and Kelly cells. FASEB J. 18, 1462-1464
5. Gruber, M., Hu, C. J., Johnson, R. S., Brown, E. J., Keith, B., and Simon, M. C. (2007) Acute postnatal ablation of Hif-2α results in anemia. Proc. Natl. Acad. Sci. U. S. A. 104, 2301-2306
6. Rankin, E. B., Biju, M. P., Liu, Q., Unger, T. L., Rha, J., Johnson, R. S., Simon, M. C., Keith, B., and Haase, V. H. (2007) Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 117, 1068-1077
7. Maxwell, P. H. (2005) The HIF pathway in cancer. Semin. Cell. Dev. Biol. 16, 523-530
8. Semenza, G. L. (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625-634
9. 2 sensing and cancer. Nat. Rev. Cancer 8, 865-873
10. Elvidge, G. P., Glenny, L., Appelhoff, R. J., Ratcliffe, P. J., Ragoussis, J., and Gleadle, J. M. (2006) Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1α, HIF-2α, and other pathways. J. Biol. Chem. 281, 15215-15226
11. Aprelikova, O., Wood, M., Tackett, S., Chandramouli, G. V., and Barrett, J. C. (2006) Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res. 66, 5641-5647
12. Warnecke, C., Weidemann, A., Volke, M., Schietke, R., Wu, X., Knaup, K. X., Hackenbeck, T., Bernhardt, W., Willam, C., Eckardt, K. U., and Wiesener, M. S. (2008) The specific contribution of hypoxia-inducible factor-2α to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors. Exp. Cell. Res. 314, 2016-2027
13. Denko, N., Schindler, C., Koong, A., Laderoute, K., Green, C., and Giaccia, A. (2000) Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin. Cancer Res. 6, 480-487
14. Wang, V., Davis, D. A., Haque, M., Huang, L. E., and Yarchoan, R. (2005) Differential gene up-regulation by hypoxia-inducible factor-1α and hypoxia-inducible factor-2α in HEK293T cells. Cancer Res. 65, 3299-3306
15. Kenny, P. A., Enver, T., and Ashworth, A. (2005) Receptor and secreted targets of Wnt-1/β-catenin signalling in mouse mammary epithelial cells. BMC Cancer 5, 3
16. Togashi, A., Katagiri, T., Ashida, S., Fujioka, T., Maruyama, O., Wakumoto, Y., Sakamoto, Y., Fujime, M., Kawachi, Y., Shuin, T., and Nakamura, Y. (2005) Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Cancer Res. 65, 4817-4826
17. Warnecke, C., Griethe, W., Weidemann, A., Jurgensen, J. S., Willam, C., Bachmann, S., Ivashchenko, Y., Wagner, I., Frei, U., Wiesener, M., and Eckardt, K. U. (2003) Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. FASEB J. 17, 1186-1188
18. Sowter, H. M., Raval, R. R., Moore, J. W., Ratcliffe, P. J., and Harris, A. L. (2003) Predominant role of hypoxia-inducible transcription factor (Hif)-1α versus Hif-2α in regulation of the transcriptional response to hypoxia. Cancer Res. 63, 6130-6134
19. Wiesener, M. S., Munchenhagen, P. M., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A., Jurgensen, J. S., Gruber, G., Maxwell, P. H., Loning, S. A., Frei, U., Maher, E. R., Grone, H. J., and Eckardt, K. U. (2001) Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas. Cancer Res. 61, 5215-5222
20. Rosenberger, C., Mandriota, S., Jurgensen, J. S., Wiesener, M. S., Horstrup, J. H., Frei, U., Ratcliffe, P. J., Maxwell, P. H., Bachmann, S., and Eckardt, K. U. (2002) Expression of hypoxiainducible factor-1α and -2α in hypoxic and ischemic rat kidneys. J. Am. Soc. Nephrol. 13, 1721-1732
21. Weidemann, A., Klanke, B., Wagner, M., Volk, T., Willam, C., Wiesener, M. S., Eckardt, K. U., and Warnecke, C. (2008) Hypoxia, via stabilization of hypoxia-inducible factor HIF-1α is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem. J. 409, 233-242
22. Mole, D. R., Blancher, C., Copley, R. R., Pollard, P. J., Gleadle, J. M., Ragoussis, J., and Ratcliffe, P. J. (2009) Genome-wide association of hypoxia-inducible factor (HIF)-1α and HIF-2α DNA binding with expression profiling of hypoxia-inducible transcripts. J. Biol. Chem. 284, 16767-16775
23. Bulankina, A. V., Deggerich, A., Wenzel, D., Mutenda, K., Wittmann, J. G., Rudolph, M. G., Burger, K. N., and Höning, S. (2009) TIP47 functions in the biogenesis of lipid droplets. J. Cell Biol. 185, 641-655
24. Bickel, P. E., Tansey, J. T., and Welte, M. A. (2009) PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim. Biophys. Acta 1791, 419-440
25. Chi, J. T., Wang, Z., Nuyten, D. S., Rodriguez, E. H., Schaner, M. E., Salim, A., Wang, Y., Kristensen, G. B., Helland, A., Borresen-Dale, A. L., Giaccia, A., Longaker, M. T., Hastie, T., Yang, G. P., van de Vijver, M. J., and Brown, P. O. (2006) Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med. 3, e47
26. Whitmer, J. T., Idell-Wenger, J. A., Rovetto, M. J., and Neely, J. R. (1978) Control of fatty acid metabolism in ischemic and hypoxic hearts. J. Biol. Chem. 253, 4305-4309
27. Gordon, G. B., Barcza, M. A., and Bush, M. E. (1977) Lipid accumulation of hypoxic tissue culture cells. Am. J. Pathol. 88, 663-678
28. Hull, F. E., Radloff, J. F., and Sweeley, C. C. (1975) β-Hydroxy fatty acid production during fatty acid oxidation by heart mitochondria. Recent. Adv. Stud. Cardiac. Struct. Metab. 7, 13-21
29. Zhang, H., Gao, P., Fukuda, R., Kumar, G., Krishnamachary, B., Zeller, K. I., Dang, C. V., and Semenza, G. L. (2007) HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11, 407-420
30. Belanger, A. J., Luo, Z., Vincent, K. A., Akita, G. Y., Cheng, S. H., Gregory, R. J., and Jiang, C. (2007) Hypoxia-inducible factor 1 mediates hypoxia-induced cardiomyocyte lipid accumulation by reducing the DNA binding activity of peroxisome proliferator-activated receptor α/retinoid X receptor. Biochem. Biophys. Res. Commun. 364, 567-572
31. Krishnan, J., Suter, M., Windak, R., Krebs, T., Felley, A., Montessuit, C., Tokarska-Schlattner, M., Aasum, E., Bogdanova, A., Perriard, E., Perriard, J. C., Larsen, T., Pedrazzini, T., and Krek, W. (2009) Activation of a HIF1α-PPARγ axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell. Metab. 9, 512-524
32. Belanger, A. J., Lu, H., Date, T., Liu, L. X., Vincent, K. A., Akita, G. Y., Cheng, S. H., Gregory, R. J., and Jiang, C. (2002) Hypoxia up-regulates expression of peroxisome proliferator-activated receptor γ angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1α. J. Mol. Cell. Cardiol. 34, 765-774
33. Saarikoski, S. T., Rivera, S. P., and Hankinson, O. (2002) Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxia. FEBS Lett. 530, 186-190
34. Fan, B., Ikuyama, S., Gu, J. Q., Wei, P., Oyama, J., Inoguchi, T., and Nishimura, J. (2009) Oleic acid-induced ADRP expression requires both AP-1 and PPAR response elements, and is reduced by Pycnogenol through mRNA degradation in NMuLi liver cells. Am. J. Physiol. Endocrinol. Metab. 297, E112-E123
35. Rankin, E. B., Rha, J., Selak, M. A., Unger, T. L., Keith, B., Liu, Q., and Haase, V. H. (2009) Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol. Cell. Biol. 29, 4527-4538
36. Wiesener, M. S., Jurgensen, J. S., Rosenberger, C., Scholze, C. K., Horstrup, J. H., Warnecke, C., Mandriota, S., Bechmann, I., Frei, U. A., Pugh, C. W., Ratcliffe, P. J., Bachmann, S., Maxwell, P. H., and Eckardt, K. U. (2003) Widespread hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs. FASEB J. 17, 271-273
37. Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B., and Simon, M. C. (2003) Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol. Cell. Biol. 23, 9361-9374
38. Lei, L., Mason, S., Liu, D., Huang, Y., Marks, C., Hickey, R., Jovin, I. S., Pypaert, M., Johnson, R. S., and Giordano, F. J. (2008) Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein. Mol. Cell. Biol. 28, 3790-3803
39. Imamura, T., Kikuchi, H., Herraiz, M. T., Park, D. Y., Mizukami, Y., Mino-Kenduson, M., Lynch, M. P., Rueda, B. R., Benita, Y., Xavier, R. J., and Chung, D. C. (2009) HIF-1α and HIF-2α have divergent roles in colon cancer. Int. J. Cancer 124, 763-771
40. Ducharme, N. A., and Bickel, P. E. (2008) Lipid droplets in lipogenesis and lipolysis. Endocrinology 149, 942-949
41. Listenberger, L. L., Ostermeyer-Fay, A. G., Goldberg, E. B., Brown, W. J., and Brown, D. A. (2007) Adipocyte differentiation-related protein reduces the lipid droplet association of adipose triglyceride lipase and slows triacylglycerol turnover. J. Lipid Res. 48, 2751-2761
42. Bostrom, P., Magnusson, B., Svensson, P. A., Wiklund, O., Boren, J., Carlsson, L. M., Stahlman, M., Olofsson, S. O., and Hulten, L. M. (2006) Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler. Thromb. Vasc. Biol. 26, 1871-1876
43. Sluimer, J. C., and Daemen, M. J. (2009) Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J. Pathol. 218, 7-29
44. Jiang, G., Li, T., Qiu, Y., Rui, Y., Chen, W., and Lou, Y. (2007) RNA interference for HIF-1α inhibits foam cells formation in vitro. Eur. J. Pharmacol. 562, 183-190
45. Byrne, C. D. (2009) Hypoxia and non alcoholic fatty liver disease. Clin. Sci. (Lond.) 118, 397-400
46. Bostrom, P., Andersson, L., Li, L., Perkins, R., Hojlund, K., Boren, J., and Olofsson, S. O. (2009) The assembly of lipid droplets and its relation to cellular insulin sensitivity. Biochem. Soc. Trans. 37, 981-985
47. Varela, G. M., Antwi, D. A., Dhir, R., Yin, X., Singhal, N. S., Graham, M. J., Crooke, R. M., and Ahima, R. S. (2008) Inhibition of ADRP prevents diet-induced insulin resistance. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G621-G628
48. Bell, M., Wang, H., Chen, H., McLenithan, J. C., Gong, D. W., Yang, R. Z., Yu, D., Fried, S. K., Quon, M. J., Londos, C., and Sztalryd, C. (2008) Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance. Diabetes 57, 2037-2045
49. Miyanari, Y., Atsuzawa, K., Usuda, N., Watashi, K., Hishiki, T., Zayas, M., Bartenschlager, R., Wakita, T., Hijikata, M., and Shimotohno, K. (2007) The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9, 1089-1097
50. Hagist, S., Sultmann, H., Millonig, G., Hebling, U., Kieslich, D., Kuner, R., Balaguer, S., Seitz, H. K., Poustka, A., and Mueller, S. (2009) In vitro-targeted gene identification in patients with hepatitis C using a genome-wide microarray technology. Hepatology 49, 378-386
51. Zhao, H., Ljungberg, B., Grankvist, K., Rasmuson, T., Tibshirani, R., and Brooks, J. D. (2006) Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med. 3, e13
52. Yao, M., Tabuchi, H., Nagashima, Y., Baba, M., Nakaigawa, N., Ishiguro, H., Hamada, K., Inayama, Y., Kishida, T., Hattori, K., Yamada-Okabe, H., and Kubota, Y. (2005) Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J. Pathol. 205, 377-387